CVS Health and Walmart are closing some of their pharmacies earlier than usual as the shortage of pharmacists forced them to do so. The companies confirmed that they would be cutting store hours due to the labor crunch.
According to CNN Business, starting in March, CVS Health and Walmart will either be cutting or shifting their pharmacy operation hours. The move is a response not only due to the staffing shortage but to the declining customer demand as well. The dwindling demand was attributed to fading COVID-19 pandemic.
Thousands of the pharmacies’ locations are affected by the reduced hours. Walmart will be closing most of its 4,600 stores in the United States at 7 p.m., which is two hours earlier, while CVS Health will cut the hours of its 6,000 pharmacies.
CVS said that the change in its operating hours would allow them to make sure that all patients are served. The company further explained that this decision is part of its “regular course of business to meet customer demand.
As for Walmart, its spokesperson said, “Walmart has a strong and incredible pharmacy team, and we are making this change to not only enhance their work-life balance but also to maintain the best level of service for our customers. By positioning our teams in the hours where our customers say they want to visit our pharmacy, we are better able to deliver excellent customer service.”
Walgreens pharmacy already cut its operating hours last year due to the same reason, but CVS Health and Walmart were only feeling the shortage this year. Meanwhile, Reuters reported that the U.S. is currently experiencing a labor shortage that started at the height of the COVID-19 pandemic. The crunch is not over yet, and the pharmacy industry is feeling the most effect at the moment.
Photo by Jack Cohen on Unsplash


Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Global Markets Slide as AI, Crypto, and Precious Metals Face Heightened Volatility
Japan Economy Poised for Q4 2025 Growth as Investment and Consumption Hold Firm
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
India–U.S. Interim Trade Pact Cuts Auto Tariffs but Leaves Tesla Out
Russian Stocks End Mixed as MOEX Index Closes Flat Amid Commodity Strength
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns
Washington Post Publisher Will Lewis Steps Down After Layoffs
Anta Sports Expands Global Footprint With Strategic Puma Stake
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Australian Household Spending Dips in December as RBA Tightens Policy
Yen Slides as Japan Election Boosts Fiscal Stimulus Expectations
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 



